23.04.2015
- In a pre-negotiated share sale agreed a year ago, Japan's Daiichi Sankyo has unloaded its entire 8.9% stake in India's mammoth generics producer Sun Pharmaceutical Industries...
29.07.2014
- Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...
09.04.2014
- Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...
02.04.2014
- The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's...
05.03.2014
- Up And Up - Long known for its struggles with infectious diseases and poverty, the continent of Africa is experiencing widespread economic growth. An increasing middle class and...
04.02.2014
- Japan's Daiichi Sankyo said it would send personnel to help resolve problems at a production facility of its drugmaking subsidiary Ranbaxy at Toansa in India's northern state of...
27.01.2014
- Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...
20.06.2013
- European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...
